A new non-invasive imaging technique using [89Zr]Zr-girentuximab has been shown to accurately detect clear-cell renal cell carcinoma, the most common form of kidney cancer, in a study led by UCLA researchers. This method can reduce unnecessary surgeries and ensure timely treatment for patients, potentially changing how the disease is diagnosed and treated. The technique targets the CA9 protein found in clear-cell renal cell carcinoma and has shown high sensitivity and specificity in detecting cancerous masses. The research team is now exploring the technique’s potential for identifying metastasis and improving post-surgery treatment outcomes.
Source link
New imaging technique accurately detects aggressive kidney cancer
